Mast Therapeutics, Inc. (MSTX) Reports In-Line Q3 Loss

Go back to Mast Therapeutics, Inc. (MSTX) Reports In-Line Q3 Loss

Form 8-K Mast Therapeutics, Inc. For: Oct 31

October 31, 2014 8:26 AM EDT

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): October 31, 2014

Mast Therapeutics,... More